Novartis Investigative Site

Fort Sam Houston, Texas 78234

0 studies enrolling now · 2 studies all time

What they study most

Neoplasms, Breast, Non-Hodgkin's Lymphoma

Studies at this site

• ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early